AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Hansen Carl L. G.
AbCellera Biologics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Baker Bros. Advisors LP(7.9%),Baker Bros. Advisors (GP) LLC(7.9%), etc.
AbCellera Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Carl L.G. Hansen(20.6%),Thermopylae Holdings Ltd.(19.2%)
AbCellera Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(8.29%)
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Lecault Veronique
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Stimart Tryn
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Booth Andrew
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Hansen Carl L. G.
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-10% Owner Thermopylae Holdings Ltd.
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Hansen Carl L. G.
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Director Montalbano John S.
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Director Hayden Michael R
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Operating Officer Lecault Veronique
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Hansen Carl L. G.
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Director Hayden Michael R
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Hansen Carl L. G.
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Booth Andrew
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-10% Owner Thermopylae Holdings Ltd.
AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Operating Officer Lecault Veronique
AbCellera Biologics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Peter Thiel(4.99%),ABE Investments LLC(3.54%), etc.
No Data